Results for tag: "Botulism Drug"

Botulism is a rare but serious paralytic illness caused by a nerve toxin produced by the bacterium Clostridium botulinum. Botulism is treated with an antitoxin, which blocks the action of the toxin and prevents further damage. The antitoxin is derived from horse serum and is administered intravenously. It is the only available treatment for botulism and is used in combination with supportive care. The botulism drug market is a niche segment of the infectious diseases drugs market. It is characterized by a limited number of players and a small number of products. The market is highly regulated and requires specialized manufacturing processes. The market is expected to grow in the coming years due to the increasing prevalence of botulism and the need for effective treatments. Some of the companies in the botulism drug market include GlaxoSmithKline, Novartis, Sanofi, and Pfizer. Show Less Read more